TESTBANK V
TietzFundamentalsOf
V V
CLINICAL CHEMISTRY AND
V V V
MOLECULAR DIAGNOSTICS V
7thEditionByCarlA.Burtis
V V V V V
TEST BANK V
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 7th Edition Test Bank
V V V V V V V V
V
V V
Table of contents: V V
I. Principles Of Laboratory Medicine
V V V V
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
V V V V V V V V
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
V V V V V V V V V V V
Chapter 3. Clinical Evaluation of Methods
V V V V V
Chapter 4. Evidence-Based Laboratory Medicine
V V V V
Chapter 5. Establishment and Use of Reference Values
V V V V V V V
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
V V V V V V V V
Chapter 7. Quality Management
V V V
II. Analytical Techniques And Instrumentation
V V V V
Chapter 8. Principles of Basic Techniques and Laboratory Safety
V V V V V V V V
Chapter 9. Optical Techniques
V V V
Chapter 10. Electrochemistry and Chemical Sensors
V V V V V
Chapter 11. Electrophoresis
V V
Chapter 12. Chromatography
V V
Chapter 13. Mass Spectrometry
V V V
Chapter 14. Enzyme and Rate Analyses
V V V V V
Chapter 15. Immunochemical Techniques
V V V
Chapter 16 Automation V V
Chapter 17. Point-of-Care Instrumentation
V V V
III. AnalytesV
Chapter 18. Amino Acids, Peptides, and Proteins
V V V V V V
Chapter 19. Serum EnzymesV V V
Chapter 20. Tumor Markers and Cancer Genes
V V V V V V
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
V V V V V V V V V V V
Chapter 22. CarbohydratesV V
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
V V V V V V V V V
Chapter 24. Electrolytes and Blood Gases
V V V V V
Chapter 25. Hormones V V
Chapter 26. Catecholamines and Serotonin
V V V V
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
V V V V V V
Chapter 28. Hemoglobin, Iron, and Bilirubin
V V V V V
Chapter 29. Porphyrins and Porphyrias
V V V V
Chapter 30. Therapeutic Drugs and Their Management
V V V V V V
Chapter 31. Clinical Toxicology
V V V
Chapter 32. Toxic Metals V V V
IV. Pathophysiology
V
Chapter 33. Diabetes V V
,Chapter 34. Cardiovascular Disease
V V V
Chapter 35. Kidney Disease
V V V
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
V V V V V V V V V V
Chapter 37. Liver Disease
V V V
Chapter 38. Gastrointestinal and Pancreatic Diseases
V V V V V
Chapter 39. Disorders of Bone and Mineral Metabolism
V V V V V V V
Chapter 40. Disorders of the Pituitary Gland
V V V V V V
Chapter 41. Disorders of the Adrenal Cortex
V V V V V V
Chapter 42. Thyroid Disorders
V V V
Chapter 43. Reproduction-Related Disorders
V V V
Chapter 44. Pregnancy and Prenatal Testing
V V V V V
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
V V V V V V V V
Chapter 46. Pharmacogenetics
V V
V. Molecular Diagnostics
V V
Chapter 47. Principles of Molecular Biology
V V V V V
Chapter 48. Nucleic Acid Techniques and Applications
V V V V V V
Chapter 49. Genomes and Nucleic Acid Alterations
V V V V V V
, Tietz Fundamentals of Clinical Chemistry and MolecularDiagnostics, 7e Burtis Test Bank
V V V V V V V V V V
Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory MedicineTest Bank
V V V V V V V V V
MULTIPLE CHOICE V
1. An individual working in a clinical chemistry laboratory is married to a sales representative who
V V V V V V V V V V V V V V V
works for a company that sells chemistry laboratory supplies. When the laboratory manager requ
V V V V V V V V V V V V V
ests a list of needed supplies, cost of supplies, and vendors, this individual only recommends the s
V V V V V V V V V V V V V V V V
pouse’s company as the vendor. This is considered to be a(n):
V V V V V V V V V V
a. accounting issue. V
b. possible conflict of interest. V V V
c. maintenance of confidentiality issue. V V V
d. problem with resource allocation. V V V
ANS: B V
Concern has been raised over the interrelationships between practitioners in the medical field and c
V V V V V V V V V V V V V V
ommercial suppliers of drugs, devices, equipment, etc., to the medical profession.
V V V V V V V V V V
Similarly, relationships have been scrutinized between clinical laboratorians and manufacturers a
V V V V V V V V V V
nd providers of diagnostic equipment and supplies. These concerns led the National Institutes of H
V V V V V V V V V V V V V V
ealth (NIH) in 1995 to require official institutional review of financial disclosure by researchers an
V V V V V V V V V V V V V V
d management of situations in which disclosure indicates potential conflicts of interest.
V V V V V V V V V V V
DIF: 1 REF: Page 4-5 V V OBJ: 6 | 7 V V V
2. A patient visits her physician stating that her prescribed painkiller is not working to reduce the p
V V V V V V V V V V V V V V V V
ain following her recent surgery. A friend of the patient claims that the same painkiller “worked
V V V V V V V V V V V V V V V V
wonders” to reduce her pain after the same surgery. The physician states that the difference in th
V V V V V V V V V V V V V V V V
e effect of the drug might be caused by
V V V V V V V V
, which is studied in pharmacogen V V V V V
etics.
a. epidemiology
b. an inherited disease V V
c. a conflict of interest V V V
d. a genetic variation in drug-metabolizing enzymes
V V V V V
ANS: D V
Pharmacogenetics is the study of the genetic variation of drug metabolism between individuals V V V V V V V V V V V V
.
DIF: 1 REF: Page 3 V V V OBJ: 1 V
3. John works in a molecular diagnostics laboratory and receives a blood sample that has the name
V V V V V V V V V V V V V V V
of a close friend printed on the bar-
V V V V V V V V
coded label. The genetic test that is ordered on the friend’s sample would provide diagnostic inf
V V V V V V V V V V V V V V V
ormation about a disorder that has a poor prognosis, and the test is usually performed by John. H
V V V V V V V V V V V V V V V V V
e asks a fellow employee to analyze the sample for him and not divulge the results. This ethical i
V V V V V V V V V V V V V V V V V V
ssue concerns: V
a. confidentiality of patient genetic and medical information. V V V V V V
b. a conflict of interest. V V V
c. resource allocation. V
d. diagnostic accuracy. V
TietzFundamentalsOf
V V
CLINICAL CHEMISTRY AND
V V V
MOLECULAR DIAGNOSTICS V
7thEditionByCarlA.Burtis
V V V V V
TEST BANK V
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 7th Edition Test Bank
V V V V V V V V
V
V V
Table of contents: V V
I. Principles Of Laboratory Medicine
V V V V
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
V V V V V V V V
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
V V V V V V V V V V V
Chapter 3. Clinical Evaluation of Methods
V V V V V
Chapter 4. Evidence-Based Laboratory Medicine
V V V V
Chapter 5. Establishment and Use of Reference Values
V V V V V V V
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
V V V V V V V V
Chapter 7. Quality Management
V V V
II. Analytical Techniques And Instrumentation
V V V V
Chapter 8. Principles of Basic Techniques and Laboratory Safety
V V V V V V V V
Chapter 9. Optical Techniques
V V V
Chapter 10. Electrochemistry and Chemical Sensors
V V V V V
Chapter 11. Electrophoresis
V V
Chapter 12. Chromatography
V V
Chapter 13. Mass Spectrometry
V V V
Chapter 14. Enzyme and Rate Analyses
V V V V V
Chapter 15. Immunochemical Techniques
V V V
Chapter 16 Automation V V
Chapter 17. Point-of-Care Instrumentation
V V V
III. AnalytesV
Chapter 18. Amino Acids, Peptides, and Proteins
V V V V V V
Chapter 19. Serum EnzymesV V V
Chapter 20. Tumor Markers and Cancer Genes
V V V V V V
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
V V V V V V V V V V V
Chapter 22. CarbohydratesV V
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
V V V V V V V V V
Chapter 24. Electrolytes and Blood Gases
V V V V V
Chapter 25. Hormones V V
Chapter 26. Catecholamines and Serotonin
V V V V
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
V V V V V V
Chapter 28. Hemoglobin, Iron, and Bilirubin
V V V V V
Chapter 29. Porphyrins and Porphyrias
V V V V
Chapter 30. Therapeutic Drugs and Their Management
V V V V V V
Chapter 31. Clinical Toxicology
V V V
Chapter 32. Toxic Metals V V V
IV. Pathophysiology
V
Chapter 33. Diabetes V V
,Chapter 34. Cardiovascular Disease
V V V
Chapter 35. Kidney Disease
V V V
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
V V V V V V V V V V
Chapter 37. Liver Disease
V V V
Chapter 38. Gastrointestinal and Pancreatic Diseases
V V V V V
Chapter 39. Disorders of Bone and Mineral Metabolism
V V V V V V V
Chapter 40. Disorders of the Pituitary Gland
V V V V V V
Chapter 41. Disorders of the Adrenal Cortex
V V V V V V
Chapter 42. Thyroid Disorders
V V V
Chapter 43. Reproduction-Related Disorders
V V V
Chapter 44. Pregnancy and Prenatal Testing
V V V V V
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
V V V V V V V V
Chapter 46. Pharmacogenetics
V V
V. Molecular Diagnostics
V V
Chapter 47. Principles of Molecular Biology
V V V V V
Chapter 48. Nucleic Acid Techniques and Applications
V V V V V V
Chapter 49. Genomes and Nucleic Acid Alterations
V V V V V V
, Tietz Fundamentals of Clinical Chemistry and MolecularDiagnostics, 7e Burtis Test Bank
V V V V V V V V V V
Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory MedicineTest Bank
V V V V V V V V V
MULTIPLE CHOICE V
1. An individual working in a clinical chemistry laboratory is married to a sales representative who
V V V V V V V V V V V V V V V
works for a company that sells chemistry laboratory supplies. When the laboratory manager requ
V V V V V V V V V V V V V
ests a list of needed supplies, cost of supplies, and vendors, this individual only recommends the s
V V V V V V V V V V V V V V V V
pouse’s company as the vendor. This is considered to be a(n):
V V V V V V V V V V
a. accounting issue. V
b. possible conflict of interest. V V V
c. maintenance of confidentiality issue. V V V
d. problem with resource allocation. V V V
ANS: B V
Concern has been raised over the interrelationships between practitioners in the medical field and c
V V V V V V V V V V V V V V
ommercial suppliers of drugs, devices, equipment, etc., to the medical profession.
V V V V V V V V V V
Similarly, relationships have been scrutinized between clinical laboratorians and manufacturers a
V V V V V V V V V V
nd providers of diagnostic equipment and supplies. These concerns led the National Institutes of H
V V V V V V V V V V V V V V
ealth (NIH) in 1995 to require official institutional review of financial disclosure by researchers an
V V V V V V V V V V V V V V
d management of situations in which disclosure indicates potential conflicts of interest.
V V V V V V V V V V V
DIF: 1 REF: Page 4-5 V V OBJ: 6 | 7 V V V
2. A patient visits her physician stating that her prescribed painkiller is not working to reduce the p
V V V V V V V V V V V V V V V V
ain following her recent surgery. A friend of the patient claims that the same painkiller “worked
V V V V V V V V V V V V V V V V
wonders” to reduce her pain after the same surgery. The physician states that the difference in th
V V V V V V V V V V V V V V V V
e effect of the drug might be caused by
V V V V V V V V
, which is studied in pharmacogen V V V V V
etics.
a. epidemiology
b. an inherited disease V V
c. a conflict of interest V V V
d. a genetic variation in drug-metabolizing enzymes
V V V V V
ANS: D V
Pharmacogenetics is the study of the genetic variation of drug metabolism between individuals V V V V V V V V V V V V
.
DIF: 1 REF: Page 3 V V V OBJ: 1 V
3. John works in a molecular diagnostics laboratory and receives a blood sample that has the name
V V V V V V V V V V V V V V V
of a close friend printed on the bar-
V V V V V V V V
coded label. The genetic test that is ordered on the friend’s sample would provide diagnostic inf
V V V V V V V V V V V V V V V
ormation about a disorder that has a poor prognosis, and the test is usually performed by John. H
V V V V V V V V V V V V V V V V V
e asks a fellow employee to analyze the sample for him and not divulge the results. This ethical i
V V V V V V V V V V V V V V V V V V
ssue concerns: V
a. confidentiality of patient genetic and medical information. V V V V V V
b. a conflict of interest. V V V
c. resource allocation. V
d. diagnostic accuracy. V
